In another study, Terashima et al. showed that the TGF-β type I receptor inhibitor R-268712 prevents glomerular sclerosis, providing insights into the potential of ALK5 inhibitors to curb fibrosis in SSc.52 This evidence concerns the gene TGFBR1 and systemic sclerosis.